Genes Predict Mesothelioma Treatment Response

Mesothelioma is a fast-growing cancer triggered by exposure to asbestos.  It is often treated with multiple modalities, including chemotherapy.  As more is understood about the impact of genetics on medication response, chemotherapy for cancers like mesothelioma is moving away from a ‘one-size-fits-all’ approach to a more tailored approach based on individual cellular characteristics. 

University of Chicago researchers have released the results of genetic studies they hope will shed some light on why some mesothelioma patients respond well to pemetrexed (Alimta) while others do not.

This is a copyrighted article hence cannot publish the entire thing here. But for more information on this you can visit the site at http://www.survivingmesothelioma.com/